Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Topiramate(Conviban) and Empagliflozin(Jardiance) is Considered a Good Option for the Treatment of Obesity

NCT04043702 is registered in ClinicalTrials.gov with Ministry of Health and Population, Egypt as lead sponsor.

NCT NCT04043702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04043702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Topiramate(Conviban) and Empagliflozin(Jardiance) is Considered a Good Option for the Treatment of Obesity
Lead sponsor
Ministry of Health and Population, Egypt
Phase
Observational
Overall status
Completed
Start date
January 4, 2019
Completion date
July 29, 2019
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity